National and Kapodistrian University of Athens
Γενετικός έλεγχος ασθενών με σύνδρομο μακρού QT και σύνδρομο Brugada
Abstract
dc:descriptionLong QT syndrome (LQTS) and Brugada syndrome (BrS) are inherited cardiac arrhythmias that may lead to sudden death in patients with structurally normal heart and are characterized by variable penetrance and expressivity. Mutations in the genes of the major cardiac K+ and Na+ channels are responsible for LQTS in 70% of cases, while mutations of the Na+ cardiac channel gene are responsible for BrS in 20% of cases. The genetic basis of these syndromes in the Greek population has not been previously explored. We developed a uniform and efficient methodology for genetic testing of the major cardiac ion channel genes my means of PCR-SSCP analysis and DNA sequencing that was applied to patients with LQTS and BrS. In particular, we genetically screened 18 patients with a high, intermediate and low probability of LQTS and 15 patients with definite or borderline diagnosis of BrS, based on clinical criteria. Genetic testing was positive in 78% of patients with a high probability for LQTS and in 43% of patients with a definite diagnosis of BrS. In LQTS, the majority of detected mutations have been previously described and all belonged to types LQT1 and LQT2 of the syndrome, while in BrS all detected mutations were novel. In addition, 28 single nucleotide polymorphisms were detected, 6 of which are novel. Existing genotype-phenotype correlations were successfully used to predict the genetic type in one case and were thereafter found efficiently predictive of the genetic test results of the rest of the patients. After the completion of genetic analysis of the probands, all family relatives that consented were genetically screened. LQTS cascade family screening revealed 12 carriers among 17 relatives, 5 of which did not fulfill the criteria for a clinical diagnosis. BrS cascade family screening revealed 7 carriers among 14 relatives, 5 of which did not fulfill the criteria for a clinical diagnosis. All LQTS probands and relative carriers received β blocker treatment and have remained completely asymptomatic in 1-5 years follow-up. Our results are in accordance with international data that genetic testing of the major ion channel genes is efficient in genotyping the majority of LQTS patients with a strong clinical diagnosis, while in BrS, genotyping efficiency was found higher than expected. In total, the Greek genetic pool was found to differentiate, without significant diversions. Genetic testing is a strong diagnostic tool for revealing subclinical and silent forms of the syndromes in probands’ families, while identification of carrier status may contribute substantially in patient management in terms of constant follow-up, risk stratification and prophylactic measures and treatment.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Κόττα, Χριστίνα-Μαρία
- Kotta, Maria-Christina
Subjects
dc:subject × 20- Σύνδρομο μακρού QT
- Σύνδρομο Brugada
- Αιφνίδιος καρδιακός θάνατος
- Ηλεκτροκαρδιογράφημα
- Γενετικός έλεγχος
- Μεταλλάξεις
- Μονονουκλεοτιδικοί πολυμορφισμοί
- Long QT syndrome
- Brugada syndrome
- Sudden cardiac death
- Electrocardiogram
- Genetic testing
- Mutations
- Single nucleotide polymorhisms
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Κλινική Ιατρική
- Medical and Health Sciences
- Basic Medicine
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/28553